Chief Financial Officer

Senior Vice President, Head of Research

Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 2025

Kyverna Therapeutics to Host Conference Call on Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis

KYVERNA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation Into Kyverna Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Kyverna Therapeutics announces updated data from Phase 1 IITs of KYV-101

Associate Director, Accounting

Kyverna Therapeutics is seeking an experienced GL AP Accounting Consultant to manage their offshore accounts payable process and general ledger accounting. The role involves leading financial close processes, enhancing financial systems, and ensuring compliance with accounting standards.

Associate Director , Accounting (Contractor)

VP of Human Resources

Sr. Director, Talent Acquisition

Sign up with Google

Sign in with Google